2 completed, 1 unknown. 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Not applicable | 1 | Completed 1 |
Follow Cancer of Mouth: new trials by email Literature Review of Cancer of Mouth trials Research Report on Cancer of Mouth
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer Pembrolizumab, Tadalafil - Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma | Phase 2 | Completed | University of California, San Diego | 7 | 2020-04-07 | 2026-02-12 |
| Adjuvant Radiotherapy in Early Stage Oral Cancers Post-operative adjuvant radiotherapy - Cancer of Mouth, Cancer of the Tongue | Not applicable | Completed | Tata Memorial Hospital | 392 | 2018-08-02 | 2026-01-16 |
| uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer 68Ga-NOTA-AE105 PET/CT - Oral Cancer, Oropharyngeal Cancer | Phase 2 | Unknown | Copenhagen University Hospital, Rigshospitalet | 90 | 2016-11-01 | 2016-11-10 |
Head and Neck Neoplasms (3) · Mouth Neoplasms (3) · Neoplasms (2) · Carcinoma (1) · Esophageal Neoplasms (1) · Neoplasm Metastasis (1) · Neoplasms by Site (1) · Oropharyngeal Neoplasms (1) · Parkinson Disease 4, Autosomal Dominant Lewy Body (1) · Pyridoxine-dependent epilepsy (1) · Squamous Cell Carcinoma of Head and Neck (1) · Tongue Neoplasms (1)
Mouth Diseases (3) · Stomatognathic Diseases (3) · Neoplasms by Site (2) · Carcinoma, Squamous Cell (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Esophageal Diseases (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1) · Neoplastic Processes (1) · Otorhinolaryngologic Diseases (1) · Otorhinolaryngologic Neoplasms (1)
Tadalafil (1) · pembrolizumab (1)
Copenhagen University Hospital, Rigshospitalet (1) · Tata Memorial Hospital (1) · University of California, San Diego (1)
Denmark (1) · India (1) · United States (1)
Joseph Califano (1) · Sudhir V Nair, MS, MCh (1)